Research and Markets: Scleroderma Pipeline Highlights Report - 2014-2017
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/7kzx2j/scleroderma) has announced the addition of the "Scleroderma Pipeline Highlights - 2014 Update" report to their offering.
The latest report Scleroderma Pipeline Highlights - 2014 Update, provides most up-to-date information on key pipeline molecules in the global Scleroderma market. It covers emerging therapies for Scleroderma in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Key Topics Covered:
1. Scleroderma Pipeline by Stages
2. Scleroderma Pipeline by Drug Class
3. Scleroderma Pipeline by Company
4. Scleroderma Phase 3 Clinical Trial Insights
5. Scleroderma Phase 2 Clinical Trial Insights
6. Scleroderma Phase 1 Clinical Trial Insights
7. Scleroderma Preclinical Research Insights
8. Scleroderma Discovery Stage Insights
10. Research Methodology
For more information visit http://www.researchandmarkets.com/research/7kzx2j/scleroderma